What is the recommended treatment for bacterial conjunctivitis in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis in Adults

For mild bacterial conjunctivitis in adults, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, with fluoroquinolones (moxifloxacin, gatifloxacin) or aminoglycosides (tobramycin) being effective first-line options. 1, 2

First-Line Treatment Approach

  • Topical antibiotics are recommended even for mild cases as they accelerate clinical and microbiological remission by days 2-5, reduce transmissibility, and allow earlier return to work 1, 2

  • The most convenient or least expensive broad-spectrum option is appropriate, as there is no clinical evidence suggesting superiority of any particular antibiotic for uncomplicated cases 2

  • Fluoroquinolones are highly effective options:

    • Moxifloxacin 0.5% ophthalmic solution is FDA-approved for bacterial conjunctivitis, dosed one drop in the affected eye 3 times daily for 7 days 3
    • Gatifloxacin ophthalmic solution is also FDA-approved with similar efficacy 4
    • These agents achieve excellent ocular tissue penetration and cover common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 5, 3
  • Alternative effective options include:

    • Aminoglycosides (tobramycin) 1, 6
    • Polymyxin B/trimethoprim 1
    • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics when access is limited 1, 2

Moderate to Severe Cases

  • Obtain conjunctival cultures and Gram staining before initiating treatment if you observe copious purulent discharge, marked inflammation, or severe pain 1, 2, 6

  • Compounded topical antibiotics such as vancomycin may be required for resistant organisms like MRSA 2

  • Consider MRSA if standard therapy fails, as bacterial resistance is an increasing concern 1, 2

Critical Special Situations Requiring Different Management

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy, not topical treatment alone 1, 2, 6
  • Add saline lavage to promote comfort and faster resolution 1
  • Daily follow-up is mandatory until resolution 2

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy rather than topical treatment 1, 2, 6
  • Follow-up evaluation is important as treatment failure occurs in up to 19% of cases 2

Follow-Up and Red Flags

  • Instruct patients to return if no improvement after 3-4 days of treatment 1, 6

  • Refer to ophthalmology immediately for:

    • Visual loss or moderate to severe pain 1, 6
    • Severe purulent discharge or corneal involvement 1, 6
    • Conjunctival scarring 1, 6
    • Lack of response to therapy or recurrent episodes 1, 6

Important Pitfalls to Avoid

  • Do not use topical corticosteroids unless under close ophthalmologic supervision, as they may prolong bacterial shedding and worsen infection 6

  • Advise patients not to wear contact lenses during treatment 3

  • Emphasize strict hand hygiene and avoiding sharing personal items to prevent transmission 6

  • Be aware that increasing bacterial resistance, particularly MRSA, is a growing concern that may require alternative antibiotics 1, 2

  • Poor adherence to frequent dosing regimens contributes to treatment failure 1

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.